Earnings

Moderna expects $18.4 billion in 2021 sales from Covid vaccine, chief medical officer to depart

A Moderna (COVID-19) vaccine is seen at the LA Mission homeless shelter on Skid Row, in Los Angeles, California, U.S., February 10, 2021.

Lucy Nicholson | Reuters

Moderna said Thursday it expects to make $18.4 billion in sales from its Covid-19 vaccine this year.

In releasing its fourth-quarter earnings, Moderna also said its chief medical officer, Tal Zaks, will leave the company in late September.

Shares of Moderna were up 3.9% in premarket trading.

The news comes a day after the company said it was expecting to produce at least 700 million Covid vaccine doses this year. It also said it expects to produce up to 1.4 billion Covid-19 vaccine doses in 2022.

Pfizer, which also has a vaccine authorized for use in the United States, said earlier this month that it expected to sell about $15 billion in doses this year.

This is a developing story. Please check back for updates.

Products You May Like

Articles You May Like

Morgan Stanley tops earnings estimates on better-than-expected trading, investment banking results
Here are smart steps to take now to make tax filing easier for 2021
Virgin Galactic shares erase 2021 gains after Richard Branson’s stake sale
Mortgage refinance demand hits lowest level in over a year, and homebuyers retreat, too
I paid off $28,000 in debt in 3 years and became a money coach: Here’s my best advice

Leave a Reply

Your email address will not be published. Required fields are marked *